stella
beta
Intrinsic Validity of Molecular Marker(s) Detection on Tissular Tumoral DNA to Predict the Efficacy of 177Lutetium-PSMA-617 (Lu-PSMA) Treatment for Castration-resistant Metastatic Prostate Cancer — Stella
Recruiting
Back to Castration-resistant Metastatic Prostate Cancer trials
Not a traditional drug trial — this study doesn't follow the standard phase structure.
Trial locations
(5 sites)
France
Centre Jean PERRIN, Clermont-Ferrand
CHU de Grenoble, La Tronche
Hospices Civiles de Lyon, Pierre-Bénite
Hôpital privé de la Loire, Saint-Etienne
Centre Paul STRAUSS, Strasbourg
View full record on ClinicalTrials.gov